Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
DexCom Inc (DXCM)  
$128.37 1.72 (1.36%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 389,580,000
Market Cap: 50.01(B)
Last Volume: 1,778,975 Avg Vol: 1,913,734
52 Week Range: $75.49 - $140.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  487
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 214,480 283,298 303,316 571,262
Total Sell Value $28,881,982 $37,155,070 $39,545,240 $69,827,197
Total People Sold 7 12 14 16
Total Sell Transactions 14 29 47 80
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 1713
  Page 9 of 69  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dolan Matthew Vincent SVP Corporate Development   •       –      –    2022-03-09 4 D $406.06 $655,782 D/D (1,615) 8,820     -
   Selvaraj Shelly Ramasamy SVP Chief Information Officer   •       –      –    2022-03-09 4 D $406.06 $757,296 D/D (1,865) 13,820     -
   Sayer Kevin R Chairman, CEO & President   •       •      –    2022-03-09 4 D $406.06 $4,054,476 D/D (9,985) 100,883     -
   Patterson Chad EVP, Global Marketing   •       –      –    2022-03-09 4 D $406.06 $739,429 D/D (1,821) 16,004     -
   Regan Barry J. EVP Global Operations   •       –      –    2022-03-09 4 D $406.06 $268,403 D/D (661) 17,451     -
   Abbey Donald EVP Quality Regulatory Affairs   •       –      –    2022-03-09 4 D $406.06 $1,392,368 D/D (3,429) 50,229     -
   Pacelli Steven Robert Managing Dir., Dexcom Ventures   •       –      –    2022-03-09 4 D $406.06 $1,392,368 D/D (3,429) 35,925     -
   Sylvain Jereme M EVP, Chief Financial Officer   •       –      –    2022-03-09 4 D $406.06 $792,217 D/D (1,951) 18,008     -
   Balo Andrew K EVP, Global Medical Affairs   •       –      –    2022-03-09 4 D $406.06 $1,392,774 D/D (3,430) 15,615     -
   Leach Jacob Steven EVP Chief Technology Officer   •       –      –    2022-03-08 4 A $0.00 $7 D/D 6,741 79,019     -
   Flynn Paul R EVP Global Revenue   •       –      –    2022-03-08 4 A $0.00 $5 D/D 5,297 19,150     -
   Shrishrimal Sumi SVP Chief Risk Officer   •       –      –    2022-03-08 4 A $0.00 $3 D/D 2,889 15,146     -
   Stern Sadie EVP Chief Human Resources Off   •       –      –    2022-03-08 4 A $0.00 $5 D/D 5,297 18,758     -
   Dolan Matthew Vincent SVP Corporate Development   •       –      –    2022-03-08 4 A $0.00 $3 D/D 2,889 10,435     -
   Selvaraj Shelly Ramasamy SVP Chief Information Officer   •       –      –    2022-03-08 4 A $0.00 $3 D/D 2,889 15,685     -
   Sayer Kevin R Chairman, CEO & President   •       •      –    2022-03-08 4 A $0.00 $16 D/D 16,251 110,868     -
   Patterson Chad EVP, Global Marketing   •       –      –    2022-03-08 4 A $0.00 $5 D/D 5,297 17,825     -
   Regan Barry J. EVP Global Operations   •       –      –    2022-03-08 4 A $0.00 $5 D/D 4,984 18,112     -
   Abbey Donald EVP Quality Regulatory Affairs   •       –      –    2022-03-08 4 A $0.00 $5 D/D 4,984 53,658     -
   Pacelli Steven Robert Managing Dir., Dexcom Ventures   •       –      –    2022-03-08 4 A $0.00 $5 D/D 4,984 39,354     -
   Brown Micheal Jon EVP Chief Legal Officer   •       –      –    2022-03-08 4 A $0.00 $12 D/D 12,038 12,038     -
   Sylvain Jereme M EVP, Chief Financial Officer   •       –      –    2022-03-08 4 A $0.00 $5 D/D 5,297 19,959     -
   Balo Andrew K EVP, Global Medical Affairs   •       –      –    2022-03-08 4 A $0.00 $5 D/D 4,984 19,045     -
   Dolan Matthew Vincent *Officer   •       –      –    2022-03-04 3 IO $0.00 $0 D/D 0 7,546 -82%     
   Sylvain Jereme M EVP, Chief Financial Officer   •       –      –    2022-03-04 4 AS $422.94 $253,764 D/D (600) 14,662 -82%     
  1713 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 69
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us